SYNOVUS FINANCIAL CORP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,160
+33.3%
48,0000.0%0.00%0.0%
Q2 2023$69,120
-31.4%
48,0000.0%0.00%0.0%
Q1 2023$100,800
+85.8%
48,0000.0%0.00%0.0%
Q4 2022$54,240
-30.5%
48,0000.0%0.00%0.0%
Q3 2022$78,000
+23.8%
48,0000.0%0.00%0.0%
Q2 2022$63,000
-18.2%
48,0000.0%0.00%0.0%
Q1 2022$77,000
-22.2%
48,0000.0%0.00%0.0%
Q4 2021$99,00048,0000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$271,9250.08%
Geneos Wealth Management Inc. 427,400$897,5400.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$25,2000.02%
Vivaldi Capital Management LP 19,261$40,4480.01%
Beacon Capital Management, LLC 12,605$26,4710.01%
Atria Wealth Solutions, Inc. 263,300$552,9300.01%
Wealthspire Advisors, LLC 183,862$386,1110.01%
BARRETT & COMPANY, INC. 4,984$10,4660.01%
OSAIC HOLDINGS, INC. 1,271,760$2,670,6560.01%
Ameritas Advisory Services, LLC 45,302$94,8560.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders